Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Total Debt: 2021-2024

Historic Total Debt for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $4.9 million.

  • ProQR Therapeutics N.V's Total Debt rose 213.29% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 213.29%. This contributed to the annual value of $4.9 million for FY2024, which is 105467.16% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Total Debt of $4.9 million as of FY2024, which was up 105,467.16% from $4,643 recorded in FY2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Total Debt peaked at $52.2 million during FY2021, and registered a low of $4,643 during FY2023.
  • In the last 3 years, ProQR Therapeutics N.V's Total Debt had a median value of $2.5 million in 2022 and averaged $2.5 million.
  • Its Total Debt has fluctuated over the past 5 years, first slumped by 99.82% in 2023, then skyrocketed by 105,467.16% in 2024.
  • ProQR Therapeutics N.V's Total Debt (Yearly) stood at $52.2 million in 2021, then crashed by 95.12% to $2.5 million in 2022, then slumped by 99.82% to $4,643 in 2023, then soared by 105,467.16% to $4.9 million in 2024.